A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter’s syndrome.

Matthew S. Davids,Kerry A. Rogers,Svitlana Tyekucheva,Samantha Pazienza,Sarah Renner,Josie Montegaard,Michael Rocchio,Udochukwu Ihuoma,Caron A. Jacobson,David C. Fisher,Jennifer R. Brown,Philip A Thompson

A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter’s syndrome.

2020

Matthew S. Davids
Kerry A. Rogers
Svitlana Tyekucheva
Samantha Pazienza
Sarah Renner
Josie Montegaard
Michael Rocchio
Udochukwu Ihuoma
Caron A. Jacobson
David C. Fisher
Jennifer R. Brown
Philip A Thompson

8004Background: While therapeutic options for CLL have improved, patients (pts) who develop Richter’s Syndrome (RS) still have a poor prognosis. Chemoimmunotherapy regimens such as R-EPOCH lead to ...

Keywords:

Pediatrics
Physical therapy
Venetoclax
Phases of clinical research
Series (stratigraphy)
s syndrome
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations